Epilepsy trials recruiting in Alabama

All Epilepsy trials nationally

Cities in Alabama

Recruiting trials in Alabama

• A Multi-site Feasibility Clinical Trial of Retraining and Control Therapy (ReACT), a Mind and Body Treatment for Pediatric Functional Seizures
  NCT05819268 · Phase: Not applicable (e.g. observational or device study) · Ages: 11 Years to 18 Years · Sex: All (male and female) · Alabama: Birmingham
• A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
  NCT04462770 · Phase: Phase 3 · Ages: 2 Years and older · Sex: All (male and female) · Alabama: Birmingham
• A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
  NCT05667142 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · Alabama: Mobile
• AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
  NCT06063850 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Alabama: Birmingham
• Diagnosing Epilepsy To EffeCT Change
  NCT07110337 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · Alabama: Birmingham
• Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
  NCT07110454 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female) · Alabama: Birmingham
• Establishment of an Interdisciplinary Functional Neurological Disorder (FND) Treatment Program and Development of a Clinical Care Pathway for FND
  NCT06362161 · Phase: Not specified · Ages: 8 Years to 89 Years · Sex: All (male and female) · Alabama: Birmingham
• Investigating Dynamic Interactions in Distributed Cognitive Control Networks
  NCT05927974 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Alabama: Birmingham
• Retraining and Control Therapy (ReACT) R33 Phase
  NCT06007053 · Phase: Not applicable (e.g. observational or device study) · Ages: 11 Years to 18 Years · Sex: All (male and female) · Alabama: Birmingham
• Retraining and Control Therapy (ReACT)- Adults
  NCT06570954 · Phase: Not applicable (e.g. observational or device study) · Ages: 19 Years and older · Sex: All (male and female) · Alabama: Birmingham
• Retraining and Control Therapy (ReACT): Sense of Control and Symptom Expectations as Targets of a Treatment for PNES
  NCT05096273 · Phase: Not applicable (e.g. observational or device study) · Ages: 11 Years to 18 Years · Sex: All (male and female) · Alabama: Birmingham
• Stimulation-Induced Changes in Fronto-Limbic Network
  NCT05854160 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Alabama: Birmingham
• Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
  NCT05104983 · Phase: Phase 2 · Ages: 1 Day to 6 Months · Sex: All (male and female) · Alabama: Birmingham
• Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
  NCT07594119 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Alabama: Huntsville
• Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
  NCT05135091 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Alabama: Birmingham